SAN DIEGO -- Proteintech Genomics, a leader in antibody-based multiplexed solutions for single-cell multiomics, today announced the launch of its MultiPro® Human Discovery Panel, a groundbreaking antibody panel designed to transform single-cell multiomics research. This new panel enables scientists to profile 325 proteins alongside whole transcriptome analysis within single cells, offering a multiomic approach that [...]

RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced that it has closed the divestiture of its clinical services business to Audax Private Equity in a transaction valued at approximately $650 million. Avantor expects the transaction to [...]

On October 10, Shimadzu signed an agreement related to comprehensive collaboration with Waseda University, with the aim of promoting mutual collaboration, including research and development, and the fostering of human resources. Based on this collaborative agreement, both parties will work to develop new products and foster highly specialized human resources through collaborative research aiming at [...]

BILLERCA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that the European Unified Patent Court (UPC) has ruled in favor of its NanoString business, invalidating European Patent No. 2794928B1 (the “928 Patent”), which has been asserted by 10x Genomics against NanoString’s CosMx® Spatial Molecular Imager (SMI) products in Europe. Today’s ruling follows the May 2024 decision [...]

Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, today announced the appointment of Marc Montserrat as its new Chief Executive Officer. In addition, founding CEO Thomas Ybert, PhD, has transitioned to a new Chief Scientific Officer role, where he will continue to [...]

Biognosys’ proprietary P2 Plasma Enrichment System enables plasma proteome profiling with unprecedented depth and throughput, both as contract research and in-house via licensing  By offering the combination of NULISA™ affinity-based assays and TrueDiscovery® mass spectrometry-based plasma profiling with P2 Plasma Enrichment, Biognosys offers the industry’s most comprehensive solutions for plasma proteomics  Spectronaut® workflows for high-performance computing environments, [...]

DeNovix Releases Higher Magnification CellDrop Models Optimized for Yeast, Stem Cells and Other Small Cells WILMINGTON, DE – DeNovix announces the expansion of the CellDrop Automated Cell Counter range with the commercial release of two new models, the CellDrop FLxi and CellDrop BFx. The new models include higher magnification optics designed for the quantification and [...]

WILMINGTON, DE – DeNovix introduces the DS-8X Eight Channel Spectrophotometer, a new addition to the DS-Series Quantification Range. The DS-8X is designed to equip labs with higher throughput, high performance, full spectrum 1 µL UV-Vis measurements (190 – 840 nm) for DNA, RNA and protein quantification. Based on the award-winning DS-11 technology, DS-Series instruments offer [...]

Research Triangle Park, NC – Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of research-grade IsoTag™ AAV reagent, for the purification of adeno associated viral vectors (AAV). The research-grade IsoTag™ AAV reagent marks a significant advancement from its prototype grade. It maintains the same non-chromatographic purification capabilities, but now provides [...]

The board of Phase Holographic Imaging (PHI) has today appointed Anders Månsson as the new CEO of PHI as of November 1, 2024. The current CEO, Patrik Eschricht, will remain in his role until November 1, 2024, and ensure a smooth handover to Anders Månsson. Goran Dubravčić, Chairman of the Board, says: “I and the [...]